BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11157490)

  • 21. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD; Eaves AC; Eaves CJ
    Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cells.
    Willems R; Henckaerts E; Lenjou M; Nijs G; Rodrigus I; Moulijn AC; Slegers H; Berneman ZN; Van Bockstaele DR
    Ann Hematol; 2001 Jan; 80(1):17-25. PubMed ID: 11233770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line.
    Cornelissen JJ; Wognum AW; Ploemacher RE; Frassoni F; Wagemaker G; Hagemeijer A; Löwenberg B
    Leukemia; 1997 Jan; 11(1):126-33. PubMed ID: 9001428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo.
    Jiang X; Ng E; Yip C; Eisterer W; Chalandon Y; Stuible M; Eaves A; Eaves CJ
    Blood; 2002 Nov; 100(10):3731-40. PubMed ID: 12393460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
    Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
    Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
    Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.
    Graham SM; Jørgensen HG; Allan E; Pearson C; Alcorn MJ; Richmond L; Holyoake TL
    Blood; 2002 Jan; 99(1):319-25. PubMed ID: 11756187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells.
    Rosler E; Brandt J; Chute J; Hoffman R
    Exp Hematol; 2000 Jul; 28(7):841-52. PubMed ID: 10907646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.
    Zhang X; Ren R
    Blood; 1998 Nov; 92(10):3829-40. PubMed ID: 9808576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells.
    Punzel M; Zhang T; Liu D; Eckstein V; Ho AD
    Exp Hematol; 2002 May; 30(5):464-72. PubMed ID: 12031653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
    Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preincubation with endothelial cell monolayers increases gene transfer efficiency into human bone marrow CD34(+)CD38(-) progenitor cells.
    Chute JP; Saini A; Wells M; Clark W; Wu A; St Louis D; Blair P; Harlan D; Kaushal S
    Hum Gene Ther; 2000 Dec; 11(18):2515-28. PubMed ID: 11119422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
    Petzer AL; Eaves CJ; Barnett MJ; Eaves AC
    Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
    Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.